文献速递产科

妊娠期及产后宫颈鳞状上皮内病变的诊断与管理

Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum.
PubMed 文献 · Obstet Gynecol · 2024-03-29

围产期保健为宫颈癌风险人群提供重要健康机会,妊娠不改变宫颈癌筛查方案。ASCCP基于风险的管理中阴道镜检查阈值为即刻CIN3或癌风险4%,但实际风险可更高。妊娠期诊断CIN2-3不推荐治疗,产后需进一步评估或治疗。

要点

  • 妊娠不改变宫颈癌筛查方案,阴道镜检查指征不变。
  • 妊娠期不推荐治疗CIN2-3,产后需进一步评估。
  • 妊娠期宫颈活检不增加并发症,但宫颈管搔刮和快速治疗不可接受。

核心结论

  • 围产期管理目标是提高妊娠期诊断而非产后诊断的宫颈癌结局,并促进产后对较低级别病变的进一步评估和治疗。

研究设计与样本

  • 原文未报告研究设计。

主要发现

  • 妊娠期诊断的CIN倾向于稳定,产后经常消退,但并非普遍。
  • 妊娠期阴道镜检查可能具有挑战性。
  • 妊娠期活检主观上与出血增加相关,但不增加并发症。
  • 分娩方式不确定影响产后CIN的持续。

关键数值与推荐

  • ASCCP基于风险的管理阴道镜检查阈值为即刻CIN3或癌风险4%。
  • 妊娠期CIN2-3的治疗不推荐。
  • 妊娠期切除活检保留用于怀疑恶性且阴道镜活检无法确认,以及切除活检结果会改变肿瘤或妊娠管理时。
  • 妊娠期高级别病变监测使用基于HPV的检测、细胞学和阴道镜,从诊断到产后评估每12-24周对恶化病变进行活检。

临床怎么用

  • 妊娠期阴道镜检查指征不变,但低风险CIN2-3且能可靠产后评估的个体可推迟阴道镜检查至产后。
  • 妊娠期宫颈管搔刮和快速治疗不可接受。
  • 产后护理可包括全面阴道镜评估或如有指征的快速切除手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Perinatal care provides important health care opportunities for many individuals at risk for cervical cancer. Pregnancy does not alter cervical cancer screening regimens. ASCCP risk-based management has a colposcopy threshold of a 4% immediate risk of cervical intraepithelial neoplasia (CIN) 3 or cancer, but the actual risk can be considerably higher based on current and past screening results. Improving cervical cancer outcomes with diagnosis during pregnancy rather than postpartum and facilitating further evaluation and treatment postpartum for lesser lesions are the perinatal management goals. Although colposcopy indications are unchanged in pregnancy, some individuals with lower risk of CIN 2-3 and reliable access to postpartum evaluation may defer colposcopy until after delivery. Cervical intraepithelial neoplasia diagnosed in pregnancy tends to be stable, with frequent regression postpartum, though this is not universal. Colposcopic inspection during pregnancy can be challenging. Although biopsies in pregnancy are subjectively associated with increased bleeding, they do not increase complications. Endocervical curettage and expedited treatment are unacceptable. Treatment of CIN 2-3 in pregnancy is not recommended. Excisional biopsies in pregnancy are reserved for suspicion of malignancy that cannot be confirmed by colposcopic biopsy and when excisional biopsy results would alter oncologic or pregnancy care. Surveillance of high-grade lesions in pregnancy uses human papillomavirus-based testing, cytology, and colposcopy, with biopsy of worsening lesions every 12-24 weeks from diagnosis until postpartum evaluation. Mode of delivery does not definitively affect persistence of CIN postpartum. Postpartum care may involve a full colposcopic evaluation or expedited excisional procedure if indicated.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Larish A, Long ME. Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum. Obstet Gynecol. 2024. PMID: 38547493. doi:10.1097/AOG.0000000000005566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。